Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Portfolio, program, and project management in the pharmaceutical and biotechnology industries [[electronic resource] /] / edited by Pete Harpum
| Portfolio, program, and project management in the pharmaceutical and biotechnology industries [[electronic resource] /] / edited by Pete Harpum |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, c2010 |
| Descrizione fisica | 1 online resource (352 p.) |
| Disciplina | 615.1068/4 |
| Altri autori (Persone) | HarpumPete |
| Soggetto topico |
Pharmaceutical industry - Management
Biotechnology industries - Management Project management |
| ISBN |
0-470-88896-2
1-282-55051-9 9786612550515 0-470-60378-X 0-470-60377-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries; Contents; Preface; Acknowledgments; About the Authors; Part One The Life Science Industry Context for Portfolio, Program, and Project Management; 1. A Review of Project Management in Life Science Industry Sectors; 2. The Impact of Organizational Size on Drug Project Management; 3. Drug Development in Biotechnology and How We Can Do It Better; Part Two The Portfolio, Program, and Project Management Approaches and Processes
4. An Overview of the Organization and Processes of Portfolio, Program, and Project Management5. Portfolio Management in the Pharmaceutical Industry: Balancing Corporate Need with the Reality of Delivering Products to the Market; 6. Program Management in Drug Development; 7. Project Control; 8. Managing Uncertainty in Drug Projects; 9. Managing Drug Safety Risk; 10. Developing Program Strategy; 11. Developing Products with "Added Value"; Part Three Integrating the Processes; 12. Integrated Business Processes to Support Cross-Functional Drug Development 13. Integrated Drug Development: From Cradle to Grave and from Lab to Market14. The Development of P(3)M Capability in Drug Development Organizations; 15. Implementing Portfolio, Program, and Project Management Best Practices in Drug Development Organizations; Bibliography; Index |
| Record Nr. | UNINA-9910140602803321 |
| Hoboken, N.J., : John Wiley & Sons, c2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Portfolio, program, and project management in the pharmaceutical and biotechnology industries / / edited by Pete Harpum
| Portfolio, program, and project management in the pharmaceutical and biotechnology industries / / edited by Pete Harpum |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, c2010 |
| Descrizione fisica | 1 online resource (352 p.) |
| Disciplina | 615.1068/4 |
| Altri autori (Persone) | HarpumPete |
| Soggetto topico |
Pharmaceutical industry - Management
Biotechnology industries - Management Project management |
| ISBN |
0-470-88896-2
1-282-55051-9 9786612550515 0-470-60378-X 0-470-60377-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries; Contents; Preface; Acknowledgments; About the Authors; Part One The Life Science Industry Context for Portfolio, Program, and Project Management; 1. A Review of Project Management in Life Science Industry Sectors; 2. The Impact of Organizational Size on Drug Project Management; 3. Drug Development in Biotechnology and How We Can Do It Better; Part Two The Portfolio, Program, and Project Management Approaches and Processes
4. An Overview of the Organization and Processes of Portfolio, Program, and Project Management5. Portfolio Management in the Pharmaceutical Industry: Balancing Corporate Need with the Reality of Delivering Products to the Market; 6. Program Management in Drug Development; 7. Project Control; 8. Managing Uncertainty in Drug Projects; 9. Managing Drug Safety Risk; 10. Developing Program Strategy; 11. Developing Products with "Added Value"; Part Three Integrating the Processes; 12. Integrated Business Processes to Support Cross-Functional Drug Development 13. Integrated Drug Development: From Cradle to Grave and from Lab to Market14. The Development of P(3)M Capability in Drug Development Organizations; 15. Implementing Portfolio, Program, and Project Management Best Practices in Drug Development Organizations; Bibliography; Index |
| Record Nr. | UNINA-9910813866703321 |
| Hoboken, N.J., : John Wiley & Sons, c2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||